Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting
- 1 April 2006
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 111 (3) , 333-342
- https://doi.org/10.1016/j.jconrel.2005.12.023
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 41 references indexed in Scilit:
- Matrix Metalloprotease Triggered Delivery of Cancer Chemotherapeutics from Hydrogel MatrixesBioconjugate Chemistry, 2005
- Matrix metalloproteinase–activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicityMolecular Cancer Therapeutics, 2005
- Directed evolution of retroviruses activatable by tumour-associated matrix metalloproteasesGene Therapy, 2003
- Lack of specificity of cell‐surface protease targeting of a cytotoxic hyperfusogenic gibbon ape leukaemia virus envelope glycoproteinThe Journal of Gene Medicine, 2002
- Increased Extracellular Matrix Remodeling Is Associated With Tumor Progression in Human Hepatocellular CarcinomasHepatology, 2001
- Involvement of Specific Mechanism in Plasmid DNA Uptake by Mouse Peritoneal MacrophagesBiochemical and Biophysical Research Communications, 1998
- Dual expression of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase in fibrotic human liversHepatology, 1997
- Elevated Plasma Levels of Matrix Metalloproteinase–9 (92–Kd Type Iv Collagenase/Gelatinase B) in Hepatocellular CarcinomaHepatology, 1996
- Human matrix metalloproteinase specificity studies using collagen sequence-based synthetic peptidesBiopolymers, 1996
- 2-Imino-2-methoxyethyl 1-thioglycosides: new reagents for attaching sugars to proteinsBiochemistry, 1976